Menu
A unique opening for a highly-skilled scientist for Antibody Engineering, Molecular Biology, and Drug Discovery
Symphogen has entered an exciting phase as an Antibody Center of Excellence for Servier with a continued focus on the discovery and early development of novel antibody-based therapeutic products for the treatment of cancer and other diseases. To help Symphogen on this mission the Antibody Technology team has a unique new opening for a creative and motivated Senior Scientist to support them in their efforts to discover and develop the next generation of antibody-based drug candidates.
The main objective for you will be to innovate molecular biology processes for recombinant antibody repertoire cloning and engineering using the human antibody transgenic animals and high throughput single B cell cloning workflows. This is a position that requires solid scientific expertise, attention to detail, and the ability to work in a team-oriented culture, where knowledge sharing and idea generation with peers are key for advancing next-generation antibody therapeutics.
Your main tasks and responsibilities will be:
The preferred candidate has solid experience within molecular biology and antibody drug discovery workflows and a keen interest in exploring novel antibody cloning procedures, workflows, and participation in the antibody selection process.
You have a Ph.D. degree in immunology, molecular biochemistry, or other related biological science combined with 2 years of Postdoc or Industry experience with antibody projects in drug discovery.
Furthermore, you have the following experience:
Symphogen offers a scientist position at the Antibody Center of Excellence with cutting-edge antibody technologies to help find the best leads, bring them into the clinic and finally improve the lives of cancer and autoimmune patients worldwide. The location has optimized labs and state-of-the-art equipment for antibody discovery and development including an animal facility. You will have passionate colleagues with lots of open dialogues, agility, empowerment, and fun.
Domicile: Ballerup, Copenhagen
For more details about the job or the company, please contact Unique Human Capital, CEO Jørn Duhn at E-mail: jd@uhc.dk or Client Manager Gert Vium Andersen at E-mail: gva@uhc.dk. All applications must be in English and are treated confidentially.
Symphogen A/S was founded in 2000 and was in June 2020 acquired by Servier, an international pharmaceutical company governed by a non-profit foundation. Servier’s headquarter is located in Paris, France, and has a strong international presence in 149 countries and total revenue of 4.6 billion euros and approximately 22,000 employees worldwide.
Entirely independent, the Group invests on average 25% of its total revenue (excluding generics) every year in research and development and uses all its profits for its development. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory, and neurodegenerative diseases, cancer, and diabetes, as well as by its activities in high-quality generic drugs. Servier also offers eHealth solutions beyond drug development.
In Denmark, Symphogen A/S has approximately 135 people working at the Antibody Center of Excellence of Servier in several different therapeutic areas including oncology with highly efficient antibody discovery and research technologies supported by comprehensive discovery and early development capabilities. The antibody technologies deliver best or first in class potential and are well suited for combination therapies at the core of future cancer treatment.
Read more at http://www.symphogen.com/
We are more than 200 people who work with knowledge, creativity and technology
